New 1,2,3-triazole-containing hydroxamic acids as HDACs inhibitors with chemosensitizing properties
Mendeleev Communications · 2026 · 36 (5) · 531-533
DOI: 10.71267/mencom.8054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mendeleev Communications, online erschienen am 28.07.2026. Verfasst von Yulia Romanovna Aleksandrova und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
A new series of hydroxamic acids containing a 1,2,3-triazole moiety were obtained by the cycloaddition of methyl (2-azidoethoxy)acetate to a variety of acetylenes followed by treatment with hydroxylamine. The evaluation of their inhibitory activity against HDAC1, HDAC3, and HDAC8 revealed that N-hydroxy-2-[4-(4-pentylphenyl)-1H-1,2,3- triazol-1-yl]ethoxyacetamide showed the strongest HDAC inhibition and markedly enhanced cisplatin-induced apoptosis and antiproliferative effects in A431 cells, reducing the cisplatin IC50 from 15.64 ± 0.53 to 6.46 ± 0.87 μm (p < 0.05).
Förderung
- Russian Science Foundation
Zitieren
APA
Aleksandrova, Y. R., Brel, V. K., & Neganova, M. E. (2026). New 1,2,3-triazole-containing hydroxamic acids as HDACs inhibitors with chemosensitizing properties. Mendeleev Communications, 36(5), 531-533. https://doi.org/10.71267/mencom.8054
Vancouver
Aleksandrova YR, Brel VK, Neganova ME. New 1,2,3-triazole-containing hydroxamic acids as HDACs inhibitors with chemosensitizing properties. Mendeleev Communications. 2026;36(5):531-533. doi:10.71267/mencom.8054
BibTeX
@article{Aleksandrova2026,
author = {Aleksandrova, Yulia Romanovna and Brel, Valery Kuzmich and Neganova, Margarita Evgenievna},
title = {New 1,2,3-triazole-containing hydroxamic acids as HDACs inhibitors with chemosensitizing properties},
journal = {Mendeleev Communications},
year = {2026},
volume = {36},
number = {5},
pages = {531--533},
doi = {10.71267/mencom.8054}
}
EUVIMED